# Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn

> **NCT06860399** · PHASE1,PHASE2 · COMPLETED · sponsor: **Damascus University** · enrollment: 55 (actual)

## Conditions studied

- PPHN

## Interventions

- **DRUG:** Vardenafil
- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT06860399
- **Lead sponsor:** Damascus University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06860399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06860399, "Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06860399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*